Gene therapy for hemophilia aims to provide a long-lasting or potentially curative treatment by enabling the patient’s own cells to produce the missing clotting factor (FVIII or FIX), instead of relying on regular infusions of replacement factor proteins. The gene discussed is F8; the disease is hemophilia.